Protein-DNA Interaction at the Origin of Neurological Diseases: A Hypothesis

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Journal of Alzheimer's Disease

• Publication date

  2010-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3233/JAD-2010-100189PMID 20847445
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Polymerization of murine recombinant prion protein in nucleic acid solution

  2014cited by this paper
• Amyotrophic lateral sclerosis.

  2012cited by this paper
• Acute Polyglutamine Expression in Inducible Mouse Model Unravels Ubiquitin/Proteasome System Impairment and Permanent Recovery Attributable to Aggregate Formation

  2010cited by this paper
• Nuclear Aggregation of Polyglutamine-expanded Ataxin-3

  2010cited by this paper
• Unilateral amyloid-beta25-35 injection into the rat amygdala increases the expressions of aberrant tau phosphorylation kinases.

  2010cited by this paper
• Neuropathology of Alzheimer's disease.

  2010cited by this paper
• B2 attenuates polyglutamine‐expanded androgen receptor toxicity in cell and fly models of spinal and bulbar muscular atrophy

  2010cited by this paper
• Transcriptional Profiling in the Lumbar Spinal Cord of a Mouse Model of Amyotrophic Lateral Sclerosis: A Role for Wild-Type Superoxide Dismutase 1 in Sporadic Disease?

  2010cited by this paper
• New evidences on Tau-DNA interactions and relevance to neurodegeneration.

  2010cited by this paper
• Comparative gene expression analysis in mouse models for multiple sclerosis, Alzheimer's disease and stroke for identifying commonly regulated and disease-specific gene changes.

  2010cited by this paper
• Transcriptional dysregulation of TrkA associates with neurodegeneration in spinocerebellar ataxia type 17.

  2009cited by this paper
• Mislocalization of TDP-43 in the G93A mutant SOD1 transgenic mouse model of ALS.

  2009cited by this paper
• Cytoplasmic retention of polyglutamine-expanded androgen receptor ameliorates disease via autophagy in a mouse model of spinal and bulbar muscular atrophy.

  2009cited by this paper
• Aberrant cleavage of TDP-43 enhances aggregation and cellular toxicity

  2009cited by this paper
• Emerging pathogenic pathways in the spinocerebellar ataxias.

  2009cited by this paper
• Structural insights on physiological functions and pathological effects of ±‐synuclein

  2009cited by this paper
• Amyotrophic lateral sclerosis

  2009cited by this paper
• Androgens inhibit androgen receptor promoter activation in motor neurons.

  2009cited by this paper
• Posttranslational Modification of Ataxin-7 at Lysine 257 Prevents Autophagy-Mediated Turnover of an N-Terminal Caspase-7 Cleavage Fragment

  2009cited by this paper
• Accumulated Amyloid-β Peptide and Hyperphosphorylated Tau Protein: Relationship and Links in Alzheimer's Disease

  2009cited by this paper
• Analysis of Gene Expression in Parkinson's Disease: Possible Involvement of Neurotrophic Support and Axon Guidance in Dopaminergic Cell Death

  2009cited by this paper
• Target Identification for CNS Diseases by Transcriptional Profiling

  2009cited by this paper
• Prion protein misfolding and disease.

  2009cited by this paper
• The p62 antibody reveals various cytoplasmic protein aggregates in spinocerebellar ataxia type 6.

  2009cited by this paper
• [Molecular-targeted therapy for motor neuron disease].

  2009cited by this paper
• Pathogenesis‐targeting therapeutics for spinal and bulbar muscular atrophy (SBMA)

  2009cited by this paper
• Genome wide profiling of altered gene expression in the neocortex of Alzheimer's disease

  2009cited by this paper
• The carboxy-terminal fragment of α1A calcium channel preferentially aggregates in the cytoplasm of human spinocerebellar ataxia type 6 Purkinje cells

  2009cited by this paper
• Comparative prion disease gene expression profiling using the prion disease mimetic, cuprizone

  2009cited by this paper
• Structural and dynamic aspects related to oligomerization of apo SOD1 and its mutants

  2009influential reference
• Polymorphism of the SOD1-DNA aggregation species can be modulated by DNA.

  2008cited by this paper
• Linking Abeta and tau in late-onset Alzheimer's disease: a dual pathway hypothesis.

  2008cited by this paper
• A prion disease of cervids: chronic wasting disease.

  2008cited by this paper
• Spinocerebellar ataxia type 6 knockin mice develop a progressive neuronal dysfunction with age-dependent accumulation of mutant CaV2.1 channels

  2008cited by this paper
• Huntingtin Modulates Transcription, Occupies Gene Promoters In Vivo, and Binds Directly to DNA in a Polyglutamine-Dependent Manner

  2008cited by this paper
• Prion infection

  2008cited by this paper
• Mutant huntingtin and mitochondrial dysfunction.

  2008cited by this paper
• Molecular pathogenesis and cellular pathology of spinocerebellar ataxia type 7 neurodegeneration

  2008cited by this paper
• Histone deacetylase inhibitors: therapeutic agents and research tools for deciphering motor neuron diseases.

  2008cited by this paper
• Update on the pathogenesis of Parkinson’s disease

  2008cited by this paper
• Binding to the Minor Groove of the Double-Strand, Tau Protein Prevents DNA from Damage by Peroxidation

  2008cited by this paper
• Intriguing nucleic-acid-binding features of mammalian prion protein.

  2008cited by this paper
• Molecular mechanisms of prion pathogenesis.

  2008cited by this paper
• Mitochondria and Huntington's Disease Pathogenesis

  2008cited by this paper
• Susceptibility of cell substrates to PrPSc infection and safety control measures related to biological and biotherapeutical products

  2008cited by this paper
• Comprehensive transcriptional profiling of prion infection in mouse models reveals networks of responsive genes

  2008cited by this paper
• Why is the amyloid beta peptide of Alzheimer's disease neurotoxic?

  2008cited by this paper
• Polyglutamine Expansion Reduces the Association of TATA-binding Protein with DNA and Induces DNA Binding-independent Neurotoxicity*

  2008cited by this paper
• Physiology of the prion protein.

  2008cited by this paper
• Atrophin proteins: an overview of a new class of nuclear receptor corepressors

  2008cited by this paper
• Transgenics, toxicity and therapeutics in rodent models of mutant SOD1-mediated familial ALS.

  2008cited by this paper
• Neuropathology, biochemistry, and biophysics of alpha-synuclein aggregation.

  2007cited by this paper
• Structural Principles of Tau and the Paired Helical Filaments of Alzheimer’s Disease

  2007cited by this paper
• CAG repeat disorder models and human neuropathology: similarities and differences

  2007cited by this paper
• Is the ubiquitin-proteasome system impaired in Huntington’s disease?

  2007cited by this paper
• Prion: the chameleon protein

  2007cited by this paper
• Interaction between Alzheimer's Aβ1-42 Peptide and DNA Detected by Surface Plasmon Resonance

  2007cited by this paper
• How do ALS-associated mutations in superoxide dismutase 1 promote aggregation of the protein?

  2007cited by this paper
• GSK-3 inhibitors for Alzheimer’s disease

  2007cited by this paper
• Prions

  2007cited by this paper
• dAtaxin-2 Mediates Expanded Ataxin-1-Induced Neurodegeneration in a Drosophila Model of SCA1

  2007cited by this paper
• DNA is a template for accelerating the aggregation of copper, zinc superoxide dismutase.

  2007influential reference
• Time-Dependent DNA Condensation Induced by Amyloid β-Peptide

  2007cited by this paper
• Time-dependent DNA condensation induced by amyloid beta-peptide.

  2007cited by this paper
• Tauopathies

  2007cited by this paper
• Drug targeting of dysregulated transcription in Huntington's disease.

  2007cited by this paper
• Pathogenesis and molecular targeted therapy of spinal and bulbar muscular atrophy

  2007cited by this paper
• Nuclear Localization of Ataxin-3 Is Required for the Manifestation of Symptoms in SCA3: In Vivo Evidence

  2007cited by this paper
• Properties of human Cav2.1 channel with a spinocerebellar ataxia type 6 mutation expressed in Purkinje cells.

  2007cited by this paper
• Trinucleotide repeat disorders.

  2007cited by this paper
• Molecular pathogenesis of spinocerebellar ataxia type 6

  2007cited by this paper
• Metal-free superoxide dismutase forms soluble oligomers under physiological conditions: A possible general mechanism for familial ALS

  2007cited by this paper
• Tau protein binds to pericentromeric DNA: a putative role for nuclear tau in nucleolar organization

  2006cited by this paper
• Transcriptional repression induces a slowly progressive atypical neuronal death associated with changes of YAP isoforms and p73

  2006cited by this paper
• Abeta and tau form soluble complexes that may promote self aggregation of both into the insoluble forms observed in Alzheimer's disease.

  2006cited by this paper
• Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis

  2006cited by this paper
• Oxidative stress induces nuclear translocation of C-terminus of alpha-synuclein in dopaminergic cells.

  2006cited by this paper
• A hypothesis on prion disorders: are infectious, inherited, and sporadic causes so distinct?

  2006cited by this paper
• Molecular pathogenesis of spinocerebellar ataxias.

  2006cited by this paper
• Pathogenesis, animal models and therapeutics in spinal and bulbar muscular atrophy (SBMA).

  2006cited by this paper
• TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis.

  2006cited by this paper
• Transcriptional Abnormalities in Huntington's Disease

  2006cited by this paper
• Statistical inference of chromosomal homology based on gene colinearity and applications to Arabidopsis and rice

  2006cited by this paper
• Ataxin-3 Represses Transcription via Chromatin Binding, Interaction with Histone Deacetylase 3, and Histone Deacetylation

  2006cited by this paper
• Unexpected clinicopathological phenotype linked to small elongation of CAG repeat in SCA1 gene

  2006cited by this paper
• Paradoxical aggregation versus oligomerisation properties of mutant and wild-type huntingtin fragments.

  2006cited by this paper
• Tau phosphorylation and aggregation in Alzheimer's disease pathology

  2006cited by this paper
• Structure, folding, and misfolding of Cu,Zn superoxide dismutase in amyotrophic lateral sclerosis.

  2006cited by this paper
• Human prion diseases: molecular and clinical aspects.

  2005cited by this paper
• Tau Suppression in a Neurodegenerative Mouse Model Improves Memory Function

  2005cited by this paper
• Intracellular Abeta42 activates p53 promoter: a pathway to neurodegeneration in Alzheimer's disease.

  2005cited by this paper
• An integrative approach to gain insights into the cellular function of human ataxin-2.

  2005cited by this paper
• Accelerated amyloid deposition, neurofibrillary degeneration and neuronal loss in double mutant APP/tau transgenic mice.

  2005cited by this paper
• Intracellular Aβ42 activates p53 promoter: a pathway to neurodegeneration in Alzheimer's disease

  2005influential reference
• Conversion of a-helices into ,f-sheets features in the formation of the scrapie prion proteins

  2005cited by this paper
• Polyglutamine-expanded ataxin-7 inhibits STAGA histone acetyltransferase activity to produce retinal degeneration.

  2005cited by this paper
• HAP1 and intracellular trafficking.

  2005cited by this paper
• Tau aggregation is driven by a transition from random coil to beta sheet structure.

  2005cited by this paper
• Infectious disease: Unravelling SARS lethality

  2005cited by this paper
• Neuronal dysfunction in a polyglutamine disease model occurs in the absence of ubiquitin-proteasome system impairment and inversely correlates with the degree of nuclear inclusion formation.

  2005cited by this paper

• Modeling genotype–protein interaction and correlation for Alzheimer’s disease: a multi-omics imaging genetics study

  2024cites this paper
• Systemic exposure to bacterial amyloid curli alters the gut mucosal immune response and the microbiome, exacerbating Salmonella-induced arthritis

  2023cites this paper
• Evaluation of Amyloid Inhibitor Efficiency to Block Bacterial Survival.

  2022cites this paper
• Identification and characterization of the Hfq bacterial amyloid region DNA interactions.

  2021cites this paper
• Mobility of Bacterial Protein Hfq on dsDNA: Role of C-Terminus-Mediated Transient Binding.

  2021cites this paper
• Type I interferon response drives neuroinflammation and synapse loss in Alzheimer disease.

  2020cites this paper
• Mining Clinical Case Reports to Identify New Lines of Investigation in Alzheimer’s Disease: The Curious Case of DNase I

  2019cites this paper
• Synucleins and Gene Expression: Ramblers in a Crowd or Cops Regulating Traffic?

  2017cites this paper
• Recent progressive use of atomic force microscopy in biomedical applications

  2016cites this paper
• Trichloroacetic acid treatment as a tricky way for rapid purification of 1N/4R tau protein.

  2016cites this paper
• Using mutual information to reprogram DNA specificity of LAGLIDADG endonucleases

  2016cites this paper
• Amyloid-β containing isoaspartate 7 as potential biomarker and drug target in Alzheimer's disease

  2016cites this paper
• Zinc-Mediated Binding of Nucleic Acids to Amyloid-β Aggregates: Role of Histidine Residues

  2016cites this paper
• Amyloid-DNA Composites of Bacterial Biofilms Stimulate Autoimmunity.

  2015cites this paper
• Effect of mutations and modifications of amino acid residues on zinc-induced interaction of the metal-binding domain of β-amyloid with DNA

  2015cites this paper
• PLASMACYTOID DENDRITIC CELL-MEDIATED HUMORAL AUTOIMMUNITY

  2015cites this paper
• Predominant Role of Plasmacytoid Dendritic Cells in Stimulating Systemic Autoimmunity

  2015cites this paper
• Human Pentraxins Bind to Misfolded Proteins and Inhibit Production of Type I Interferon Induced by Nucleic Acid-Containing Amyloid.

  2015cites this paper
• Tau Protein Provides DNA with Thermodynamic and Structural Features which are Similar to those Found in Histone-DNA Complex

  2014cites this paper
• Polyanion binding accelerates the formation of stable and low‐toxic aggregates of ALS‐linked SOD1 mutant A4V

  2014cites this paper
• Pivotal Functions of Plasmacytoid Dendritic Cells in Systemic Autoimmune Pathogenesis

  2014cites this paper
• Pathological implications of nucleic acid interactions with proteins associated with neurodegenerative diseases

  2014cites this paper
• Specific binding of DNA to aggregated forms of Alzheimer's disease amyloid peptides.

  2013cites this paper
• Anomalous protein-DNA interactions behind neurological disorders.

  2013cites this paper
• Fueling autoimmunity: type I interferon in autoimmune diseases

  2013cites this paper
• Zinc-Induced Interaction of the Metal-Binding Domain of Amyloid-β Peptide with DNA

  2013cites this paper
• Binding and Repressive Activities of Apolipoprotein E3 and E4 Isoforms on the Human ApoD Promoter

  2013cites this paper
• The neurobiology of dysautonomia in Parkinson's disease.

  2013cites this paper
• Rapid generation of amyloid from native proteins in vitro.

  2013cites this paper
• Experimental characterization of the human non-sequence-specific nucleic acid interactome

  2013cites this paper
• The role of RNA in mammalian prion protein conversion

  2012cites this paper
• Cross-talk between prion protein and quadruplex-forming nucleic acids: a dynamic complex formation

  2012cites this paper
• Nucleic acid-containing amyloid fibrils potently induce type I interferon and stimulate systemic autoimmunity

  2012cites this paper
• Electrophoretic Mobility Shift Assay: Analyzing Protein - Nucleic Acid Interactions

  2012cites this paper
• Nonspecific prion protein-nucleic acid interactions lead to different aggregates and cytotoxic species.

  2012cites this paper
• α-Synuclein Induces Alterations in Adult Neurogenesis in Parkinson Disease Models via p53-mediated Repression of Notch1*

  2012cites this paper
• Kraftspektroskopie mittels optischer Pinzetten zur Untersuchung einzelner Rezeptor/Ligand-Komplexe

  2012cites this paper
• Alzheimer's disease amyloid peptides interact with DNA, as proved by surface plasmon resonance.

  2012cites this paper
• Binding with Nucleic Acids or Glycosaminoglycans Converts Soluble Protein Oligomers to Amyloid*

  2011cites this paper